Tag: PCI

TCT 2017: No advantage with extending dual antiplatelet therapy beyond six...

The primary results from the DAPT-STEMI trial suggest that 12-month dual antiplatelet therapy (DAPT) is not superior to six-month DAPT in patients who have...

Direct stenting with drug-eluting stents may be associated with better outcomes

Marco A Magalhaes (Department of Internal Medicine, MedStar Washington Hospital Center, Washington, DC, USA) and others report in Catheterization and Cardiovascular Interventions that direct...

ESC 2017: CABG is the “preferred strategy” for multivessel revascularisation in...

Data from a nationwide observational cohort study indicate that coronary artery bypass grafting (CABG) should be used instead of percutaneous coronary intervention (PCI) to...

Good care means ensuring patients are thoroughly informed

In 2010, Harlan M Krumholz wrote a commentary in the Journal of the American Medical Association (JAMA) about the need for true informed consent...

ESC 2017: Hexacath’s titanium-nitride-oxide coated stent matches Boston Scientific’s Synergy for...

During a late-breaking science session at the European Society of Cardiology (ESC) congress (26–30 August, Barcelona, Spain), Pim Tonino (Heart center Catharina Hospital, Eindhoven,...

ESC 2017: Significantly lower event rates with Orsiro than with Xience

  Results from the BIOFLOW V study indicate that patients who undergo percutaneous coronary intervention (PCI) using a sirolimus-eluting stent with a biodegradable polymer (Orsiro,...

ESC 2017: Case builds for dropping aspirin from triple therapy in...

The RE-DUAL PCI trial indicates that dual therapy with the non-vitamin K antagonist oral anticoagulant dabigatran (Pradaxa, Boehringer Ingelheim)—and not aspirin—and a P2Y12 inhibitor...

Merit Medical partners with world-renown interventional cardiologist to deliver transradial course

Merit Medical will partner with internationally renowned interventional cardiologist Ferdinand Kiemeneij to deliver the next generation in educational opportunities for interventional cardiologists and interventional...

Ruby anniversary: The key revolutions of the past 40 years

Advances in materials and techniques over the past 40 years have led to a substantial reduction in major adverse cardiovascular events. Giuliana Capretti and...

New study to evaluate safety of three-month DAPT with Xience in...

A new study, XIENCE Short DAPT, will evaluate whether three months of dual antiplatelet therapy (DAPT) is non-inferior to the standard duration of DAPT...

Roxwood Medical announces agreement with Abbott for distribution of products in...

Roxwood Medical has entered into an exclusive agreement with Abbott for distribution of Roxwood products in the USA. According to a press release, the...

Black people do not have a higher rate of mortality one...

Taisei Kobayashi (Corporal Michael J Crescenz, Veterans Affairs Medical Center, Philadelphia, USA) and others report in JAMA Cardiology that—after adjustment for demographics, comorbidities and...

Further data to support use of new-generation drug-eluting stents in women

A new study from the Women in Innovation Initiative and Drug-Eluting Stents (WIN-DES) collaborative has found that the use of new-generation drug-eluting stents is...

EuroPCR 2017: Switching to clopidogrel after one month reduces bleeding without...

Data from the TOPIC (Timing of platelet inhibition after acute coronary syndrome) study indicate that swapping a new potent P2Y212 blocker for the less...

Improving processes and outcome performance measures may be more be relevant...

Alexander C Fanaroff (Division of Cardiology, Duke University, Durham, USA) and others report in the Journal of the American College of Cardiology that nearly...

EuroPCR 2017: PCI outperforms medical management for treatment of chronic total...

According to a study presented at EuroPCR (16–19 May, Paris, France), compared with optimal medical therapy alone, percutaneous coronary intervention (PCI) significantly improves the...

Survival benefit of early intervention in non-STEMI patients is independent of...

Sameer Arora (Division of Cardiology, University of North Carolina at Chapel Hill, Chapel Hill, USA) and others report in Catheterizations and Cardiovascular Interventions that...

Dose-tracking system reduces radiation exposure to patients during PCI

A new study suggests that a novel skin dose-tracking system (Toshiba) may reduce radiation exposure in patients undergoing percutaneous coronary intervention (PCI). However, the...

EuroPCR 2017: ABSORB China and ABSORB show both comparable safety and...

Data presented from ABSORB China and ABSORB Japan at EuroPCR (16–19 May, Paris, France) show the bioresorbable scaffold Absorb (Abbott Vascular) to have comparable...

SCAI 2017: New data from PLATINUM Diversity study provide further insight...

New analyses from the PLATINUM Diversity study underscore the need for greater understanding of the clinical and nonclinical barriers that can adversely affect stent-related...

The need to determine the relevance of stent malapposition

Despite a constant evolution in stent/scaffold design, stent failure is still perceived as a clinical problem. The process of drug-eluting stent struts thinning that...

High HbA1c levels after coronary intervention may predict risk of adverse...

A new study indicates that patients with glycosylated haemoglobin A (HbA1c) ≥7 at two years after undergoing percutaneous coronary intervention (PCI) have a higher...

“Simple five-item risk score” could be used to predict bleeding risk...

Francesco Costa (Swiss Cardiovascular Center Bern, Bern University Hospital, Bern, Switzerland) and others report in The Lancet that the PRECISE-DAPT score—“a simple five-item risk...

Study indicates that Impella heart pump reduces acute kidney injury during...

A new study published in Circulation Research finds that the use of haemodynamic support with Impella 2.5 heart pump during high-risk percutaneous coronary intervention...

American College of Cardiology update appropriate use criteria for performing coronary...

The American College of Cardiology (ACC), along with several partnering organisations, has released updated appropriate use criteria for performing coronary revascularisation in patients with...

Transradial PCI reduces costs

A new study published in JACC: Cardiovascular Interventions indicates that the transradial percutaneous coronary intervention (PCI) is associated with an average cost of US$13,389...

PCI does not confer mortality benefit for diabetic patients with chronic...

Ki Hong Choi (Division of Cardiology, Department of Medicine, Cardiac and Vascular Centre, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea)...

Physicians may be overlooking patients’ desire to avoid dual antiplatelet therapy...

A study, published in Catheterization and Cardiovascular Interventions, found that most patients undergoing coronary angiography believe that—following percutaneous coronary intervention (PCI)—avoiding dual antiplatelet therapy...

“Telestenting” is possible with robotic PCI

Ryan D Madder (Frederik Meijer Heart & Vascular Institute, Spectrum Health, Grand Rapids, USA) and others report in EuroIntervention that “telestenting”—ie. when the operator...

Performing PCI in comatose survivors of cardiac arrest

Because of a significant improvement in the prehospital treatment of patients with out-of-hospital cardiac arrest, an increasing number of resuscitated, comatose patients are being...

Homemade pelvic drape significantly reduces radiation exposure to the operator during...

The RADIATION (Radiation dose in percutaneous coronary procedures through transradial approach using dedicated radiation shields) study, published in EuroIntervention, indicates that using a lower...

Perform PCI prior to TAVI in patients with both coronary artery...

Stephen Ramee (Ochsner Medical Center, New Orleans, USA) and others outline in a paper in JACC: Cardiovascular Interventions, the rationale for performing percutaneous coronary...

Infection in the setting of STEMI

The association between infections and acute coronary syndromes has been the subject of interest for many years. Recent evidence demonstrates an increased risk of...

AHA 2016: Heparin plus tirofiban is safe and effective for use...

A new study, by researchers from the Intermountain Medical Center Heart Institute (Salt Lake City, USA), indicates that there are no significant differences in...

AHA 2016: Low-dose rivaroxaban reduces clinically significant bleeding in PCI patients...

Two drug regimens involving low doses of rivaroxaban (Xarelto, Bayer)—one with a 15mg once daily dose of the drug and a P2Y12 inhibitor and...

AHA 2016: Incomplete revascularisation after PCI increases risk of adverse events...

Ehrin J Armstrong (Section of Cardiology, Denver VA Medical Center and University of Colorado School of Medicine, Aurora, USA) and others report in JACC:...

Patient enrolment complete in study assessing use of dabigatran atrial fibrillation...

  Patient enrolment into the international Phase IIIb RE-DUAL PCI study is complete. The study is evaluating the safety and efficacy of dabigatran (Pradaxa, Boehringer...

TCT 2016: Three-year data fail to show Absorb to be superior...

According to the three-year results of the ABSORB II trial, a bioresorbable vascular scaffold (Absorb, Abbott Vascular) does not provide superior vasomotor reactivity than...

TCT 2016: Women and minorities have a significantly higher risk...

Data from the PLATINUM DIVERSITY trial, which was presented at the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October–2 November, Washington DC, USA), indicates...

Adherence to medication more powerful predictor of adverse outcomes than type...

A study published in Circulation has not only found that patients who adhere to medical regimens after revascularisation have increased survival but also that...

Experience matters when stenting the left main

According to a study published in JACC: Cardiovascular Interventions, patients undergoing left main coronary artery percutaneous coronary intervention (PCI) had better outcomes when the...

Mild-to-moderate chronic kidney disease no longer associated with worse outcomes after...

A new study indicates that patients with mild-to-moderate chronic kidney disease do not have worse outcomes after undergoing percutaneous coronary intervention (PCI) with a...

Prophylactic ipsilateral ulnar compression significantly reduces risk of radial artery occlusion

Samir B Pancholy (The Wright Center for Graduate Medical Education, The Commonwealth Medical College, Scranton, USA) and others report in JACC: Cardiovascular Interventions that...

NORSTENT shows bare metal stents have improved

The NORSTENT (Norwegian coronary stent trial) study, which was presented at the 2016 European Society of Cardiology congress (27–31 August, Rome, Italy) found no...

Smartphones can help to streamline hospital transfer for myocardial infarction patients

A study published, as a research letter, in the Journal of the American College of Cardiology indicates that smartphone communication among medical teams at...

ESC 2016: Bare metal stents inferior to drug-eluting stents for saphenous...

Data from a new study, BASKET-SAVAGE, indicate that patients who receive a drug-eluting stent when undergoing percutaneous coronary intervention (PCI) in a saphenous venous...

ESC 2016: First head-to-head comparisons of prasugrel and ticagrelor shows no...

The initial results of the first randomised controlled trial—PRAGUE 18—to directly compare prasugrel (Efient, Daiichi Sankyo) with ticagrelor (Brilinta, AstraZeneca) indicate there are no...

ESC 2016: Off-hours STEMI patients do not have worse outcomes

A new analysis of data from the CHAMPION PHOENIX (Cangrelor versus standard therapy to achieve optimal management of platelet inhibition) trial, published in the...

ESC 2016: Drug-eluting stents are still preferred despite no long-term survival...

The results of NORSTENT (Norwegian coronary stent trial) indicate that second-generation drug-eluting stents do not significantly reduce the long-term risk of all-cause mortality compared...

Bolus version of Aggrastat is now approved in the USA

Medicure has received approval from the US Food and Drug Administration (FDA) for its new “bolus vial” product format for Aggrastat (tirofiban HCl). The...
Nicolas Meneveau

ESC 2016: Optical coherence tomography significantly improves functional outcomes after PCI

Nicolas Meneveau (Besancon, France) told delegates at the 2016 European Society of Cardiology (ESC) congress (27–31 August, Rome, Italy) that percutaneous coronary intervention (PCI)...

ESC 2016: Short-term DAPT is feasible with Nobori biodegradable polymer stent

The NIPPON (Nobori dual antiplatelet therapy as appropriate duration) study, presented in a hotline session at the ESC today, indicates that in patients undergoing...

No advantage with beta-blockers post PCI for stable angina patients without...

Apurva Motivala (Division of Cardiology, Columbia University, New York, USA) and others report that patients who are prescribed beta-blockers after undergoing elective percutaneous coronary...

Corindus Vascular Robotics and Acist collaborate to improve PCI workflow for...

Corindus Vascular Robotics and Acist Medical Systems have come together to provide Fairview Southdale Hospital (Edina, USA) with three leading-edge technologies that are designed...

Frequency of coronary perforation “might actually increase” given predictors include old...

Tim Kinnaird (Department of Cardiology, University Hospital of Wales, Cardiff, UK) and others report in Circulation: Coronary Interventions that older age and complex procedures,...

Essential Medical to start US trial of X-Seal 6F vascular closure...

Essential Medical has received investigational device exemption (IDE) approval from the FDA to begin the US clinical trial for X-Seal, the company’s 6F vascular...